We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Obstetrics/Gynecology Drive Growth of European Ultrasound Market

By MedImaging staff writers
Posted on 04 Jan 2007
Strong growth in the obstetrics and gynecology (Ob/Gyn) and interventional ultrasound segments are promoting the expansion of the overall European ultrasound market. More...


Developments in three-dimensional (3D) and 4D imaging capabilities, as well as the large-scale use of ultrasound systems in private clinics are facilitating this growth. Advances in transducer technology and computer-aided diagnosis (CAD) software will additionally enhance the potential for ultrasound as a critical tool in imaging the human body. Newer technologies such as elastography also hold promise for revenue augmentation.

Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, estimates that the European ultrasound market will earn revenues of U.S.$719.0 million in 2006 and reach $1063.3 million in 2013. "Advances in 3D and 4D imaging capabilities, the use of ultrasound contrast media and the increasing deployment of ultrasound for breast imaging will enhance the growth of the European ultrasound market,” noted Frost & Sullivan medical imaging team leader, Karthik Arun B. "The Ob/Gyn ultrasound segment and the ‘other' ultrasound segment [comprising hand-carried ultrasound and interventional ultrasound] will be the fastest growing in the total European ultrasound market.”

Technologic improvements in 3D and 4D imaging capabilities have reduced the scan-time for most ultrasound procedures, thereby improving workflow. Developments in ultrasound contrast media and their increasing use have greatly increased the potential for their use in diagnostic imaging as well as in interventional procedures.

However, the market for radiology ultrasound--the largest segment--will exhibit only marginal growth as a result of its market reaching saturation and ultrasound systems being used increasingly in non-radiology applications. Furthermore, intensifying demand for technologically superior systems at lower cost is placing immense pressure on participants to price their products competitively, while trying to maintain sustainable profit margins. Competition from modalities such as magnetic resonance imaging (MRI) and the matter of data volume management present considerable challenges to market growth.

As there is an increase in use of ultrasound systems outside the radiology department, market participants will need to focus on developing training programs for users, according to Frost & Sullivan. Participants will need to push for regulatory mandates for new ultrasound applications to support their rapid penetration and uptake.



Related Links:
Frost & Sullivan

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.